TapewireFind a company

person · Reporting owner

DUGAN REGINA E

Disclosed activity across 3 companies

Tapewire entity
49603
SEC CIK
0001593861

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Hewlett Packard Enterprise CoHPE · Entity 2984DirectorMay 01, 2026May 05, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Hewlett Packard Enterprise Co

Report date May 01, 2026 · Filed May 05, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect8,750 Reported balance After 2026-05-01 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2026-05-01 · Grant · Acquired 8,750 · Balance 8,750

F1: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F2: On 05/01/26, the reporting person was granted 8,750 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/01/27 or the date of Issuer's 2027 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

Common StockSEC Table I · non-derivativeDirect55,850 Reported balance Holding disclosure · report date 2026-05-01 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 55,850

Filing footnotes · ownership attribution and instrument terms

F1: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F2: On 05/01/26, the reporting person was granted 8,750 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/01/27 or the date of Issuer's 2027 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

VARIAN MEDICAL SYSTEMS INC

Report date April 15, 2021 · Filed April 16, 2021

Section 16 reporting ended · disclosed 2021-04-16. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect0 Reported balance After 2021-04-15 transaction · row 1
1 source row

Row 1 · 2021-04-15 · Disposition to issuer · Disposed 12,396 · Balance 0

F1: Disposed of pursuant to merger agreement (the "Merger Agreement") between issuer and Siemens Healthineers I GmbH and certain other parties in exchange for a cash payment of $177.50 per share of common stock.

Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect0 Reported balance After 2021-04-15 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2021-04-15 · Disposition to issuer · Disposed 1,022 · Balance 0

F2: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.

F3: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting on the earlier of February 15, 2022, or the next Annual Meeting of Stockholders that occurs after the Grant Date, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock.

Filing footnotes · ownership attribution and instrument terms

F1: Disposed of pursuant to merger agreement (the "Merger Agreement") between issuer and Siemens Healthineers I GmbH and certain other parties in exchange for a cash payment of $177.50 per share of common stock.

F2: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.

F3: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting on the earlier of February 15, 2022, or the next Annual Meeting of Stockholders that occurs after the Grant Date, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock.

ZYNGA INC

Report date May 23, 2022 · Filed May 24, 2022

Section 16 reporting ended · disclosed 2022-05-24. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class A Common StockSEC Table I · non-derivativeDirect0 Reported balance After 2022-05-23 transaction · row 1
1 source row

Row 1 · 2022-05-23 · Disposition to issuer · Disposed 210,183 · Balance 0

F1: The reported amount reflects certain non-reportable transfers from the Reporting Person to charitable organizations.

F2: Pursuant to the Agreement and Plan of Merger, dated as of January 9, 2022 (the "Merger Agreement"), by and among Take-Two Interactive Software, Inc. ("Take-Two"), Zebra MS I, Inc., Zebra MS II, Inc., and the Issuer, each share of the Issuer's class A common stock was cancelled and converted into the right to receive (i) 0.0406 shares of Take-Two common stock and (ii) $3.50 in cash, together with cash in lieu of any fractional shares of Take-Two common stock.

Filing footnotes · ownership attribution and instrument terms

F1: The reported amount reflects certain non-reportable transfers from the Reporting Person to charitable organizations.

F2: Pursuant to the Agreement and Plan of Merger, dated as of January 9, 2022 (the "Merger Agreement"), by and among Take-Two Interactive Software, Inc. ("Take-Two"), Zebra MS I, Inc., Zebra MS II, Inc., and the Issuer, each share of the Issuer's class A common stock was cancelled and converted into the right to receive (i) 0.0406 shares of Take-Two common stock and (ii) $3.50 in cash, together with cash in lieu of any fractional shares of Take-Two common stock.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
May 01, 2026 Filed May 5, 2026 21:07 UTC Hewlett Packard Enterprise Co HPE · Entity 2984 GrantRestricted Stock Units · Derivative 8,750 Not disclosed Not disclosed
Disclosure

SEC source: 0001593861-26-000004 · form4.xml · derivative · entry 2

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,750

Underlying: Common Stock · 8,750 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F2 · shares: On 05/01/26, the reporting person was granted 8,750 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/01/27 or the date of Issuer's 2027 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F2 · price: On 05/01/26, the reporting person was granted 8,750 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/01/27 or the date of Issuer's 2027 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F2 · derivative.exercise_date: On 05/01/26, the reporting person was granted 8,750 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/01/27 or the date of Issuer's 2027 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F2 · derivative.expiration_date: On 05/01/26, the reporting person was granted 8,750 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/01/27 or the date of Issuer's 2027 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:49 UTC Hewlett Packard Enterprise Co HPE · Entity 2984 Exercise / conversionRestricted Stock Units · Derivative 14,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001593861-26-000002 · form4.xml · derivative · entry 2

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 14,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F2 · shares: As previously reported, on 05/02/25, the reporting person was granted 14,235 restricted stock units ("RSUs"), all of which cliff vested on the date of Issuer's 2026 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 reflects 88.8406 dividend equivalent rights at $20.83 per RSU credited to the reporting person's account on 07/17/25, 80.5989 dividend equivalent rights at $22.96 per RSU credited to the reporting person's account on 10/17/25, 94.6123 dividend equivalent rights at $21.44 per RSU credited to the reporting person's account on 01/16/26 vested dividend equivalent rights, and a de minimis adjustment of 0.9482 due to fractional rounding of the dividend equivalent rights.

F2 · price: As previously reported, on 05/02/25, the reporting person was granted 14,235 restricted stock units ("RSUs"), all of which cliff vested on the date of Issuer's 2026 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 reflects 88.8406 dividend equivalent rights at $20.83 per RSU credited to the reporting person's account on 07/17/25, 80.5989 dividend equivalent rights at $22.96 per RSU credited to the reporting person's account on 10/17/25, 94.6123 dividend equivalent rights at $21.44 per RSU credited to the reporting person's account on 01/16/26 vested dividend equivalent rights, and a de minimis adjustment of 0.9482 due to fractional rounding of the dividend equivalent rights.

F2 · derivative.exercise_date: As previously reported, on 05/02/25, the reporting person was granted 14,235 restricted stock units ("RSUs"), all of which cliff vested on the date of Issuer's 2026 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 reflects 88.8406 dividend equivalent rights at $20.83 per RSU credited to the reporting person's account on 07/17/25, 80.5989 dividend equivalent rights at $22.96 per RSU credited to the reporting person's account on 10/17/25, 94.6123 dividend equivalent rights at $21.44 per RSU credited to the reporting person's account on 01/16/26 vested dividend equivalent rights, and a de minimis adjustment of 0.9482 due to fractional rounding of the dividend equivalent rights.

F2 · derivative.expiration_date: As previously reported, on 05/02/25, the reporting person was granted 14,235 restricted stock units ("RSUs"), all of which cliff vested on the date of Issuer's 2026 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 reflects 88.8406 dividend equivalent rights at $20.83 per RSU credited to the reporting person's account on 07/17/25, 80.5989 dividend equivalent rights at $22.96 per RSU credited to the reporting person's account on 10/17/25, 94.6123 dividend equivalent rights at $21.44 per RSU credited to the reporting person's account on 01/16/26 vested dividend equivalent rights, and a de minimis adjustment of 0.9482 due to fractional rounding of the dividend equivalent rights.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:49 UTC Hewlett Packard Enterprise Co HPE · Entity 2984 Exercise / conversionCommon Stock 14,500 $23.98 $347,710.00
Disclosure

SEC source: 0001593861-26-000002 · form4.xml · nonDerivative · entry 1

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,850

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 02, 2025 Filed May 6, 2025 21:10 UTC Hewlett Packard Enterprise Co HPE · Entity 2984 GrantRestricted Stock Units · Derivative 14,235 Not disclosed Not disclosed
Disclosure

SEC source: 0001062993-25-008654 · form4.xml · derivative · entry 2

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,235

Underlying: Common Stock · 14,235 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F2 · shares: On 05/02/25, the reporting person was granted 14,235 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/02/26 or the date of Issuer's 2026 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F2 · price: On 05/02/25, the reporting person was granted 14,235 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/02/26 or the date of Issuer's 2026 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F2 · derivative.exercise_date: On 05/02/25, the reporting person was granted 14,235 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/02/26 or the date of Issuer's 2026 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F2 · derivative.expiration_date: On 05/02/25, the reporting person was granted 14,235 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/02/26 or the date of Issuer's 2026 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

Read SEC document
April 02, 2025 Filed Apr 4, 2025 21:00 UTC Hewlett Packard Enterprise Co HPE · Entity 2984 Exercise / conversionRestricted Stock Units · Derivative 14,323 Not disclosed Not disclosed
Disclosure

SEC source: 0001062993-25-007105 · form4.xml · derivative · entry 2

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 14,323 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F2 · shares: As previously reported, on 05/10/24, the reporting person was granted 14,068 restricted stock units ("RSUs"), all of which cliff vested on 04/02/25, the date of Issuer's 2025 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 reflects 88.4780 dividend equivalent rights at $20.67 per RSU credited to the reporting person's account on 07/18/24, 88.3925 dividend equivalent rights at $20.69 per RSU credited to the reporting person's account on 10/18/24, 78.1222 dividend equivalent rights at $23.41 per RSU credited to the reporting person's account on 01/16/25, 255 vested dividend equivalent rights, and a de minimus adjustment of 0.0073 due to fractional rounding of the dividend equivalent rights.

F2 · price: As previously reported, on 05/10/24, the reporting person was granted 14,068 restricted stock units ("RSUs"), all of which cliff vested on 04/02/25, the date of Issuer's 2025 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 reflects 88.4780 dividend equivalent rights at $20.67 per RSU credited to the reporting person's account on 07/18/24, 88.3925 dividend equivalent rights at $20.69 per RSU credited to the reporting person's account on 10/18/24, 78.1222 dividend equivalent rights at $23.41 per RSU credited to the reporting person's account on 01/16/25, 255 vested dividend equivalent rights, and a de minimus adjustment of 0.0073 due to fractional rounding of the dividend equivalent rights.

F2 · derivative.exercise_date: As previously reported, on 05/10/24, the reporting person was granted 14,068 restricted stock units ("RSUs"), all of which cliff vested on 04/02/25, the date of Issuer's 2025 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 reflects 88.4780 dividend equivalent rights at $20.67 per RSU credited to the reporting person's account on 07/18/24, 88.3925 dividend equivalent rights at $20.69 per RSU credited to the reporting person's account on 10/18/24, 78.1222 dividend equivalent rights at $23.41 per RSU credited to the reporting person's account on 01/16/25, 255 vested dividend equivalent rights, and a de minimus adjustment of 0.0073 due to fractional rounding of the dividend equivalent rights.

F2 · derivative.expiration_date: As previously reported, on 05/10/24, the reporting person was granted 14,068 restricted stock units ("RSUs"), all of which cliff vested on 04/02/25, the date of Issuer's 2025 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 reflects 88.4780 dividend equivalent rights at $20.67 per RSU credited to the reporting person's account on 07/18/24, 88.3925 dividend equivalent rights at $20.69 per RSU credited to the reporting person's account on 10/18/24, 78.1222 dividend equivalent rights at $23.41 per RSU credited to the reporting person's account on 01/16/25, 255 vested dividend equivalent rights, and a de minimus adjustment of 0.0073 due to fractional rounding of the dividend equivalent rights.

Read SEC document
April 02, 2025 Filed Apr 4, 2025 21:00 UTC Hewlett Packard Enterprise Co HPE · Entity 2984 Exercise / conversionCommon Stock 14,323 $16.12 $230,886.76
Disclosure

SEC source: 0001062993-25-007105 · form4.xml · nonDerivative · entry 1

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,350

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 10, 2024 Filed May 14, 2024 21:11 UTC Hewlett Packard Enterprise Co HPE · Entity 2984 GrantRestricted Stock Units · Derivative 14,068 Not disclosed Not disclosed
Disclosure

SEC source: 0001062993-24-010236 · form4.xml · derivative · entry 2

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,068

Underlying: Common Stock · 14,068 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F2 · shares: On 05/10/24, the reporting person was granted 14,068 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/10/25 or the date of Issuer's 2025 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F2 · price: On 05/10/24, the reporting person was granted 14,068 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/10/25 or the date of Issuer's 2025 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F2 · derivative.exercise_date: On 05/10/24, the reporting person was granted 14,068 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/10/25 or the date of Issuer's 2025 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F2 · derivative.expiration_date: On 05/10/24, the reporting person was granted 14,068 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/10/25 or the date of Issuer's 2025 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

Read SEC document
April 10, 2024 Filed Apr 12, 2024 21:15 UTC Hewlett Packard Enterprise Co HPE · Entity 2984 Exercise / conversionRestricted Stock Units · Derivative 17,390 Not disclosed Not disclosed
Disclosure

SEC source: 0001062993-24-008357 · form4.xml · derivative · entry 2

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 17,390 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F2 · shares: As previously reported, on 05/05/23, the reporting person was granted 17,010 restricted stock units ("RSUs"), all of which cliff vested on 04/10/24, the date of Issuer's 2024 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 120.9959 dividend equivalent rights at $16.87 per RSU credited to the reporting person's account on 07/14/23, 123.8592 dividend equivalent rights at $16.48 per RSU credited to the reporting person's account on 10/13/23, and 135.0825 dividend equivalent rights at $16.37 per RSU credited to the reporting person's account on 01/11/24. The number of derivative securities in column 5 reflects 380 dividend equivalent rights and a de minimus adjustment of 0.0624 due to fractional rounding of the dividend equivalent rights.

F2 · price: As previously reported, on 05/05/23, the reporting person was granted 17,010 restricted stock units ("RSUs"), all of which cliff vested on 04/10/24, the date of Issuer's 2024 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 120.9959 dividend equivalent rights at $16.87 per RSU credited to the reporting person's account on 07/14/23, 123.8592 dividend equivalent rights at $16.48 per RSU credited to the reporting person's account on 10/13/23, and 135.0825 dividend equivalent rights at $16.37 per RSU credited to the reporting person's account on 01/11/24. The number of derivative securities in column 5 reflects 380 dividend equivalent rights and a de minimus adjustment of 0.0624 due to fractional rounding of the dividend equivalent rights.

F2 · derivative.exercise_date: As previously reported, on 05/05/23, the reporting person was granted 17,010 restricted stock units ("RSUs"), all of which cliff vested on 04/10/24, the date of Issuer's 2024 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 120.9959 dividend equivalent rights at $16.87 per RSU credited to the reporting person's account on 07/14/23, 123.8592 dividend equivalent rights at $16.48 per RSU credited to the reporting person's account on 10/13/23, and 135.0825 dividend equivalent rights at $16.37 per RSU credited to the reporting person's account on 01/11/24. The number of derivative securities in column 5 reflects 380 dividend equivalent rights and a de minimus adjustment of 0.0624 due to fractional rounding of the dividend equivalent rights.

F2 · derivative.expiration_date: As previously reported, on 05/05/23, the reporting person was granted 17,010 restricted stock units ("RSUs"), all of which cliff vested on 04/10/24, the date of Issuer's 2024 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 120.9959 dividend equivalent rights at $16.87 per RSU credited to the reporting person's account on 07/14/23, 123.8592 dividend equivalent rights at $16.48 per RSU credited to the reporting person's account on 10/13/23, and 135.0825 dividend equivalent rights at $16.37 per RSU credited to the reporting person's account on 01/11/24. The number of derivative securities in column 5 reflects 380 dividend equivalent rights and a de minimus adjustment of 0.0624 due to fractional rounding of the dividend equivalent rights.

Read SEC document
April 10, 2024 Filed Apr 12, 2024 21:15 UTC Hewlett Packard Enterprise Co HPE · Entity 2984 Exercise / conversionCommon Stock 17,390 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-008357 · form4.xml · nonDerivative · entry 1

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,027

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 05, 2023 Filed May 9, 2023 21:04 UTC Hewlett Packard Enterprise Co HPE · Entity 2984 GrantRestricted Stock Units · Derivative 17,010 Not disclosed Not disclosed
Disclosure

SEC source: 0001062993-23-010580 · form4.xml · derivative · entry 2

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,010

Underlying: Common Stock · 17,010 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F2 · shares: On 05/05/23, the reporting person was granted 17,010 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/05/24 or the date of Issuer's 2024 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F2 · price: On 05/05/23, the reporting person was granted 17,010 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/05/24 or the date of Issuer's 2024 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F2 · derivative.exercise_date: On 05/05/23, the reporting person was granted 17,010 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/05/24 or the date of Issuer's 2024 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F2 · derivative.expiration_date: On 05/05/23, the reporting person was granted 17,010 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/05/24 or the date of Issuer's 2024 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

Read SEC document
April 05, 2023 Filed Apr 8, 2023 01:02 UTC Hewlett Packard Enterprise Co HPE · Entity 2984 Exercise / conversionRestricted Stock Units · Derivative 9,637 Not disclosed Not disclosed
Disclosure

SEC source: 0001062993-23-008952 · form4.xml · derivative · entry 2

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,637 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F2 · shares: As previously reported, on 09/22/22, the reporting person was granted 9,476 restricted stock units ("RSUs"), all of which cliff vested on 04/05/23, the date of Issuer's 2023 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 91.2616 dividend equivalent rights at $12.46 per RSU credited to the reporting person's account on 10/07/22, and 69.1258 dividend equivalent rights at $16.45 per RSU credited to the reporting person's account on 01/13/23. The number of derivative securities in column 5 also reflects 161 vested dividend equivalent rights and a de minimus adjustment of 0.6126 due to fractional rounding of the dividend equivalent rights.

F2 · price: As previously reported, on 09/22/22, the reporting person was granted 9,476 restricted stock units ("RSUs"), all of which cliff vested on 04/05/23, the date of Issuer's 2023 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 91.2616 dividend equivalent rights at $12.46 per RSU credited to the reporting person's account on 10/07/22, and 69.1258 dividend equivalent rights at $16.45 per RSU credited to the reporting person's account on 01/13/23. The number of derivative securities in column 5 also reflects 161 vested dividend equivalent rights and a de minimus adjustment of 0.6126 due to fractional rounding of the dividend equivalent rights.

F2 · derivative.exercise_date: As previously reported, on 09/22/22, the reporting person was granted 9,476 restricted stock units ("RSUs"), all of which cliff vested on 04/05/23, the date of Issuer's 2023 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 91.2616 dividend equivalent rights at $12.46 per RSU credited to the reporting person's account on 10/07/22, and 69.1258 dividend equivalent rights at $16.45 per RSU credited to the reporting person's account on 01/13/23. The number of derivative securities in column 5 also reflects 161 vested dividend equivalent rights and a de minimus adjustment of 0.6126 due to fractional rounding of the dividend equivalent rights.

F2 · derivative.expiration_date: As previously reported, on 09/22/22, the reporting person was granted 9,476 restricted stock units ("RSUs"), all of which cliff vested on 04/05/23, the date of Issuer's 2023 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 91.2616 dividend equivalent rights at $12.46 per RSU credited to the reporting person's account on 10/07/22, and 69.1258 dividend equivalent rights at $16.45 per RSU credited to the reporting person's account on 01/13/23. The number of derivative securities in column 5 also reflects 161 vested dividend equivalent rights and a de minimus adjustment of 0.6126 due to fractional rounding of the dividend equivalent rights.

Read SEC document
April 05, 2023 Filed Apr 8, 2023 01:02 UTC Hewlett Packard Enterprise Co HPE · Entity 2984 Exercise / conversionCommon Stock 9,637 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-008952 · form4.xml · nonDerivative · entry 1

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,637

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 22, 2022 Filed Sep 26, 2022 20:45 UTC Hewlett Packard Enterprise Co HPE · Entity 2984 GrantRestricted Stock Units · Derivative 9,476 Not disclosed Not disclosed
Disclosure

SEC source: 0001062993-22-019927 · form4.xml · derivative · entry 2

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,476

Underlying: Common Stock · 9,476 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F2 · shares: On 09/22/22, the reporting person was granted 9,476 Restricted Stock Units ("RSUs"), all of which will cliff vest on the earlier of 05/05/23 or the date of Issuer's 2023 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F2 · price: On 09/22/22, the reporting person was granted 9,476 Restricted Stock Units ("RSUs"), all of which will cliff vest on the earlier of 05/05/23 or the date of Issuer's 2023 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F2 · derivative.exercise_date: On 09/22/22, the reporting person was granted 9,476 Restricted Stock Units ("RSUs"), all of which will cliff vest on the earlier of 05/05/23 or the date of Issuer's 2023 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F2 · derivative.expiration_date: On 09/22/22, the reporting person was granted 9,476 Restricted Stock Units ("RSUs"), all of which will cliff vest on the earlier of 05/05/23 or the date of Issuer's 2023 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

Read SEC document
May 23, 2022 Filed May 24, 2022 17:00 UTC ZYNGA INC ZNGA · Entity 126967 Disposition to issuerClass A Common Stock 210,183 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-031646 · doc4.xml · nonDerivative · entry 1

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · shares: The reported amount reflects certain non-reportable transfers from the Reporting Person to charitable organizations.

F2 · price: Pursuant to the Agreement and Plan of Merger, dated as of January 9, 2022 (the "Merger Agreement"), by and among Take-Two Interactive Software, Inc. ("Take-Two"), Zebra MS I, Inc., Zebra MS II, Inc., and the Issuer, each share of the Issuer's class A common stock was cancelled and converted into the right to receive (i) 0.0406 shares of Take-Two common stock and (ii) $3.50 in cash, together with cash in lieu of any fractional shares of Take-Two common stock.

Read SEC document
May 17, 2022 Filed May 19, 2022 16:46 UTC ZYNGA INC ZNGA · Entity 126967 Exercise / conversionRestricted Stock Unit · Derivative 5,548 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-030543 · doc4.xml · derivative · entry 2

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 5,548 shares

Expires 2028-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest.

F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of August 17, 2021, November 17, 2021, and February 17, 2022, and 25% of the restricted stock units vest on the earlier of May 17, 2022 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date.

Read SEC document
May 17, 2022 Filed May 19, 2022 16:46 UTC ZYNGA INC ZNGA · Entity 126967 Exercise / conversionClass A Common Stock 5,548 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-030543 · doc4.xml · nonDerivative · entry 1

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 234,046

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest.

Read SEC document
February 17, 2022 Filed Feb 22, 2022 18:11 UTC ZYNGA INC ZNGA · Entity 126967 Exercise / conversionRestricted Stock Unit · Derivative 5,547 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-011885 · doc4.xml · derivative · entry 2

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,548

Underlying: Class A Common Stock · 5,547 shares

Expires 2028-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest.

F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of August 17, 2021, November 17, 2021, and February 17, 2022, and 25% of the restricted stock units vest on the earlier of May 17, 2022 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date.

Read SEC document
February 17, 2022 Filed Feb 22, 2022 18:11 UTC ZYNGA INC ZNGA · Entity 126967 Exercise / conversionClass A Common Stock 5,547 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-011885 · doc4.xml · nonDerivative · entry 1

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 228,498

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest.

Read SEC document
November 17, 2021 Filed Nov 17, 2021 17:10 UTC ZYNGA INC ZNGA · Entity 126967 Exercise / conversionRestricted Stock Unit · Derivative 5,547 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-065161 · doc4.xml · derivative · entry 2

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,095

Underlying: Class A Common Stock · 5,547 shares

Expires 2028-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest.

F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of August 17, 2021, November 17, 2021, and February 17, 2022, and 25% of the restricted stock units vest on the earlier of May 17, 2022 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date.

Read SEC document
November 17, 2021 Filed Nov 17, 2021 17:10 UTC ZYNGA INC ZNGA · Entity 126967 Exercise / conversionClass A Common Stock 5,547 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-065161 · doc4.xml · nonDerivative · entry 1

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 222,951

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest.

Read SEC document
August 17, 2021 Filed Aug 18, 2021 18:07 UTC ZYNGA INC ZNGA · Entity 126967 Exercise / conversionRestricted Stock Unit · Derivative 5,547 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-052319 · doc4.xml · derivative · entry 2

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,642

Underlying: Class A Common Stock · 5,547 shares

Expires 2028-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest.

F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of August 17, 2021, November 17, 2021, and February 17, 2022, and 25% of the restricted stock units vest on the earlier of May 17, 2022 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date.

Read SEC document
August 17, 2021 Filed Aug 18, 2021 18:07 UTC ZYNGA INC ZNGA · Entity 126967 Exercise / conversionClass A Common Stock 5,547 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-052319 · doc4.xml · nonDerivative · entry 1

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 217,404

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest.

Read SEC document
May 17, 2021 Filed May 19, 2021 19:10 UTC ZYNGA INC ZNGA · Entity 126967 GrantRestricted Stock Unit · Derivative 22,189 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-034193 · doc4.xml · derivative · entry 3

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,189

Underlying: Class A Common Stock · 22,189 shares

Expires 2028-05-17

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest.

F3 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of August 17, 2021, November 17, 2021, and February 17, 2022, and 25% of the restricted stock units vest on the earlier of May 17, 2022 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date.

Read SEC document
May 17, 2021 Filed May 19, 2021 19:10 UTC ZYNGA INC ZNGA · Entity 126967 Exercise / conversionRestricted Stock Unit · Derivative 6,219 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-034193 · doc4.xml · derivative · entry 2

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 6,219 shares

Expires 2027-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest.

F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of August 19, 2020, November 19, 2020, and February 19, 2021, and 25% of the restricted stock units vest on the earlier of May 19, 2021 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date.

Read SEC document
May 17, 2021 Filed May 19, 2021 19:10 UTC ZYNGA INC ZNGA · Entity 126967 Exercise / conversionClass A Common Stock 6,219 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-034193 · doc4.xml · nonDerivative · entry 1

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 211,857

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest.

Read SEC document
April 15, 2021 Filed Apr 16, 2021 20:04 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Disposition to issuerRestricted Stock Units · Derivative 1,022 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-21-013930 · form4.xml · derivative · entry 2

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,022 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.

F3 · price: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting on the earlier of February 15, 2022, or the next Annual Meeting of Stockholders that occurs after the Grant Date, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock.

F3 · derivative.exercise_date: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting on the earlier of February 15, 2022, or the next Annual Meeting of Stockholders that occurs after the Grant Date, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock.

F3 · derivative.expiration_date: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting on the earlier of February 15, 2022, or the next Annual Meeting of Stockholders that occurs after the Grant Date, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock.

Read SEC document
April 15, 2021 Filed Apr 16, 2021 20:04 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Disposition to issuerCommon Stock 12,396 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-21-013930 · form4.xml · nonDerivative · entry 1

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: Disposed of pursuant to merger agreement (the "Merger Agreement") between issuer and Siemens Healthineers I GmbH and certain other parties in exchange for a cash payment of $177.50 per share of common stock.

Read SEC document
April 05, 2021 Filed Apr 5, 2021 19:30 UTC ZYNGA INC ZNGA · Entity 126967 SaleClass A Common Stock 8,950 $10.59 $94,780.50
Disclosure

SEC source: 0001209191-21-025487 · doc4.xml · nonDerivative · entry 1

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 205,638

F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 plan adopted on 08/16/2020.

F2 · price: The reported price in column 4 is a weighted average price (rounded to the nearest cent). These shares were sold in multiple transactions at prices ranging from $10.44 to $10.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 04, 2021 Filed Mar 5, 2021 17:56 UTC ZYNGA INC ZNGA · Entity 126967 SaleClass A Common Stock 8,950 $10.53 $94,243.50
Disclosure

SEC source: 0001209191-21-018330 · doc4.xml · nonDerivative · entry 1

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 214,588

F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 plan adopted on 08/16/2020.

F2 · price: The reported price in column 4 is a weighted average price (rounded to the nearest cent). These shares were sold in multiple transactions at prices ranging from $10.22 to $11.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 19, 2021 Filed Feb 22, 2021 21:14 UTC ZYNGA INC ZNGA · Entity 126967 Exercise / conversionRestricted Stock Unit · Derivative 6,219 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-013019 · doc4.xml · derivative · entry 2

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,219

Underlying: Class A Common Stock · 6,219 shares

Expires 2027-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest.

F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of August 19, 2020, November 19, 2020, and February 19, 2021, and 25% of the restricted stock units vest on the earlier of May 19, 2021 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date.

Read SEC document
February 19, 2021 Filed Feb 22, 2021 21:14 UTC ZYNGA INC ZNGA · Entity 126967 Exercise / conversionClass A Common Stock 6,219 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-013019 · doc4.xml · nonDerivative · entry 1

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 223,538

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest.

Read SEC document
February 16, 2021 Filed Feb 17, 2021 19:12 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Exercise / conversionRestricted Stock Units · Derivative 1,225 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-21-006379 · form4.xml · derivative · entry 2

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,225 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.

F2 · derivative.exercise_date: The restricted stock units vest on the earlier of February 14, 2021, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date.

F2 · derivative.expiration_date: The restricted stock units vest on the earlier of February 14, 2021, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date.

Read SEC document
February 16, 2021 Filed Feb 17, 2021 19:12 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Exercise / conversionCommon Stock 1,225 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-21-006379 · form4.xml · nonDerivative · entry 1

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,396

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.

Read SEC document
February 11, 2021 Filed Feb 16, 2021 08:51 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 GrantRestricted Stock Units · Derivative 1,022 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-005609 · form4.xml · derivative · entry 1

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,022

Underlying: Common Stock · 1,022 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.

F2 · derivative.exercise_date: The restricted stock units vest on the earlier of February 15, 2022, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date.

F2 · derivative.expiration_date: The restricted stock units vest on the earlier of February 15, 2022, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date.

Read SEC document
February 04, 2021 Filed Feb 5, 2021 18:48 UTC ZYNGA INC ZNGA · Entity 126967 SaleClass A Common Stock 8,950 $10.27 $91,916.50
Disclosure

SEC source: 0001209191-21-008295 · doc4.xml · nonDerivative · entry 1

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 217,319

F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 plan adopted on 08/16/2020.

F2 · price: The reported price in column 4 is a weighted average price (rounded to the nearest cent). These shares were sold in multiple transactions at prices ranging from $10.17 to $10.42, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 16:09 UTC ZYNGA INC ZNGA · Entity 126967 SaleClass A Common Stock 8,950 $9.79 $87,620.50
Disclosure

SEC source: 0001209191-21-001974 · doc4.xml · nonDerivative · entry 1

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 226,269

F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 plan adopted on 08/16/2020.

F2 · price: The reported price in column 4 is a weighted average price (rounded to the nearest cent). These shares were sold in multiple transactions at prices ranging from $9.73 to $9.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
December 15, 2020 Filed Dec 17, 2020 18:38 UTC ZYNGA INC ZNGA · Entity 126967 SaleClass A Common Stock 17,900 $9.00 $161,100.00
Disclosure

SEC source: 0001209191-20-064197 · doc4.xml · nonDerivative · entry 1

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 235,219

F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 plan adopted on 08/16/2020.

Read SEC document
November 19, 2020 Filed Nov 23, 2020 17:11 UTC ZYNGA INC ZNGA · Entity 126967 Exercise / conversionRestricted Stock Unit · Derivative 6,219 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-059996 · doc4.xml · derivative · entry 2

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,438

Underlying: Class A Common Stock · 6,219 shares

Expires 2027-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest.

F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of August 19, 2020, November 19, 2020, and February 19, 2021, and 25% of the restricted stock units vest on the earlier of May 19, 2021 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date.

Read SEC document
November 19, 2020 Filed Nov 23, 2020 17:11 UTC ZYNGA INC ZNGA · Entity 126967 Exercise / conversionClass A Common Stock 6,219 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-059996 · doc4.xml · nonDerivative · entry 1

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 253,119

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest.

Read SEC document
August 19, 2020 Filed Aug 20, 2020 16:59 UTC ZYNGA INC ZNGA · Entity 126967 Exercise / conversionRestricted Stock Unit · Derivative 6,218 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-047756 · doc4.xml · derivative · entry 2

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,657

Underlying: Class A Common Stock · 6,218 shares

Expires 2027-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest.

F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of August 19, 2020, November 19, 2020, and February 19, 2021, and 25% of the restricted stock units vest on the earlier of May 19, 2021 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date.

Read SEC document
August 19, 2020 Filed Aug 20, 2020 16:59 UTC ZYNGA INC ZNGA · Entity 126967 Exercise / conversionClass A Common Stock 6,218 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-047756 · doc4.xml · nonDerivative · entry 1

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 246,900

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest.

Read SEC document
May 19, 2020 Filed May 21, 2020 17:12 UTC ZYNGA INC ZNGA · Entity 126967 GrantRestricted Stock Unit · Derivative 24,875 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-031364 · doc4.xml · derivative · entry 1

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,875

Underlying: Class A Common Stock · 24,875 shares

Expires 2027-05-19

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest.

F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of August 19, 2020, November 19, 2020, and February 19, 2021, and 25% of the restricted stock units vest on the earlier of May 19, 2021 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date.

Read SEC document
May 07, 2020 Filed May 8, 2020 17:36 UTC ZYNGA INC ZNGA · Entity 126967 Exercise / conversionRestricted Stock Unit · Derivative 8,210 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-028014 · doc4.xml · derivative · entry 2

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 8,210 shares

Expires 2026-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest.

F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of August 7, 2019, November 7, 2019, and February 7, 2020, and 25% of the restricted stock units vest on the earlier of May 7, 2020 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date.

Read SEC document
May 07, 2020 Filed May 8, 2020 17:36 UTC ZYNGA INC ZNGA · Entity 126967 Exercise / conversionClass A Common Stock 8,210 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-028014 · doc4.xml · nonDerivative · entry 1

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 240,682

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest.

Read SEC document
February 14, 2020 Filed Feb 19, 2020 19:06 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 GrantRestricted Stock Units · Derivative 1,225 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-006575 · form4.xml · derivative · entry 1

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,225

Underlying: Common Stock · 1,225 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.

F2 · derivative.exercise_date: The restricted stock units vest on the earlier of February 14, 2021, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date.

F2 · derivative.expiration_date: The restricted stock units vest on the earlier of February 14, 2021, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date.

Read SEC document
February 13, 2020 Filed Feb 18, 2020 19:26 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Exercise / conversionRestricted Stock Units · Derivative 1,243 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-006188 · form4.xml · derivative · entry 2

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,243 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.

F2 · derivative.exercise_date: The restricted stock units vest on the earlier of February 15, 2020, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date.

F2 · derivative.expiration_date: The restricted stock units vest on the earlier of February 15, 2020, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date.

Read SEC document
February 13, 2020 Filed Feb 18, 2020 19:26 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Exercise / conversionCommon Stock 1,243 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-006188 · form4.xml · nonDerivative · entry 1

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,171

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 10, 2020 Filed Feb 12, 2020 21:05 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Exercise / conversionDeferred Stock Units · Derivative 1,990 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-20-005158 · form4.xml · derivative · entry 2

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,990 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of VAR common stock.

F1 · price: Each deferred stock unit represents the right to receive one share of VAR common stock.

F2 · derivative.exercise_date: The Deferred Stock Units vest in four equal quarterly installments over a 12 month period beginning February 10, 2017. Vested shares will be delivered to the reporting person on the earlier of three years from the grant date, termination/retirement date, or a change in control.

F2 · derivative.expiration_date: The Deferred Stock Units vest in four equal quarterly installments over a 12 month period beginning February 10, 2017. Vested shares will be delivered to the reporting person on the earlier of three years from the grant date, termination/retirement date, or a change in control.

Read SEC document
February 10, 2020 Filed Feb 12, 2020 21:05 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Exercise / conversionCommon Stock 1,990 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-20-005158 · form4.xml · nonDerivative · entry 1

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,928

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each deferred stock unit represents the right to receive one share of VAR common stock.

Read SEC document
February 07, 2020 Filed Feb 11, 2020 16:03 UTC ZYNGA INC ZNGA · Entity 126967 Exercise / conversionRestricted Stock Unit · Derivative 8,210 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-008267 · doc4.xml · derivative · entry 2

DUGAN REGINA E · CIK 0001593861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,210

Underlying: Class A Common Stock · 8,210 shares

Expires 2026-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest.

F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of August 7, 2019, November 7, 2019, and February 7, 2020, and 25% of the restricted stock units vest on the earlier of May 7, 2020 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.